Agnieszka Radowicz-Chil

Dr. Agnieszka Radowicz-Chil


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
JKJustyna Klusek
Justyna Klusek
ANAnna Nasierowska-Guttmejer
Anna Nasierowska-Guttmejer
AKArtur Kowalik
Artur Kowalik
IWIwona Wawrzycka
Iwona Wawrzycka
MCMagdalena Chrapek
Magdalena Chrapek
SGStanislaw Gluszek
Stanislaw Gluszek
Background: It is postulated that both individual genotype and environmental factors such as diet may modify the risk of developing colorectal cancer (CRC). The influences of GST gene polymorphism and red meat intake on CRC occurrence in the Polish population were analyzed in this study. Methods: Genotyping was performed with the qPCR method. Results: A high frequency of meat consumption was associated with an over 2-fold increase in the risk of colorectal cancer odds ratio (OR) adjusted for sex and age = 2.4, 95% confidence interval (CI); 1.3–4.4). However, after analyzing the genetic profiles, in the absence of polymorphisms of all three analyzed genes, there was no association between a high frequency of meat consumption and the occurrence of CRC. In the case of GSTM1 gene polymorphism, the high frequency of meat consumption increased the risk of CRC by almost more than 4 times (OR adjusted for sex and age = 3.8, 95% CI: 1.6–9.1). For GSTP1 gene polymorphism, a 3-fold increase in CRC risk was observed with a high frequency of meat consumption (OR adjusted for sex and age = 3.4, 95% CI: 1.4–8.1). In the case of GSTT1 gene polymorphism, the increase in risk of CRC was not statistically significant (OR adjusted for sex and age = 1.9, 95% CI: 0.4–8.5). Conclusions: The frequency of red meat intake in non-smokers increases the risk of colon cancer in the case of GST gene polymorphisms.

26 August 2021 in Archives of Medical Science
Verified
Journal Article
Open access
PKPiotr Kędzierawski
Piotr Kędzierawski
AHAnna Huruk-Kuchinka
Anna Huruk-Kuchinka
ARAgnieszka Radowicz-Chil
Agnieszka Radowicz-Chil
RMRyszard Mężyk
Ryszard Mężyk
ZRZdzisława Rugała
Zdzisława Rugała
JSJacek Sadowski
Jacek Sadowski
Introduction: Squamous cell carcinoma is the most common malignant tumour occurring in the head and neck region. It is now understood that (human papillomavirus (HPV)- positive and HPV-negative diseases are two very different clinical entities associated with different outcomes. We decided to assess p16 expression status in patients with oropharyngeal cancer and retrospectively evaluate the outcomes of the treatment.Material and methods: The evaluated group consisted of 98 consecutive patients with squamous cell carcinoma of the oropharynx treated in a combined way in Holycross Cancer Centre in Kielce in 2006–2014. For all patients p16 status was assessed based on the biological material. In 51 patients HPV infection was diagnosed. The Kaplan-Meier method was used to produce survival curves using the log-rank test and the Cox proportional hazard model was used to determine the risk factors. The following risk factors were included: HPV status (positive, negative), sex, age, smoking, histopathological grade of the tumour, clinical stage, and systemic therapy application. For HPV-positive and HPV-negative patients independent analyses were done including aforementioned factors, excluding HPV status.Results: The observation time for HPV-positive patients was significantly longer (p = 0.0008). Fifty-eight patients died, 40 patients are alive. Number of deaths in HPV-negative patients was statistically significantly higher (p = 0.0222). A statistically significant difference in the disease-free survival probability and overall survival probability between HPV-positive and HPV-negative patients was found (p = 0.0045 and p = 0.0037 respectively). For disease-free survival a statistically significant factor of the risk of recurrence was HPV infection (p = 0.0169). For HPV-positive patients, age (p = 0.0199) and smoking (p = 0.0353) were statistically significant risk factors of recurrence. For HPV-negative patients significant risk factors of recurrence were clinical stage (p = 0.0114) and systemic therapy application (p = 0.0271). For overall survival for the entire group statistically significant risk factors were absence of HPV infection (p = 0.0123), male sex (p = 0.0426), and age (p = 0.0311). For HPV-positive patients, age (p = 0.0096) and smoking (p = 0.0387) were statistically significant risk factors of death. For HPV-negative patients significant risk factors of death were clinical stage (p = 0.0120) and systemic therapy application (p = 0.0460).Conclusions: Our data show that HPV infection is a predictor of better disease-free and overall survival in patients with oropharyngeal cancer. For HPV-positive oropharyngeal cancer patients weekly given cisplatin with concurrent radiotherapy can be an alternative to three weekly given cisplatin considering effectiveness and early toxicity.

28 June 2019 in Medical Studies
Verified
Journal Article
Open access
MŻMarcin Żelezik
Marcin Żelezik
AMAnna Michalska
Anna Michalska
ARAgnieszka Radowicz-Chil
Agnieszka Radowicz-Chil
Piotr LewitowiczPiotr Lewitowicz
Piotr Lewitowicz
ANAnna Nasierowska-Guttmejer
Anna Nasierowska-Guttmejer
Wszystkich typów badań cytologicznych dotyczy problem dwuznacznych wyników, które utrudniają wdrożenie właściwych procedur leczniczych. Aby rozwiać wiele wątpliwości wynikających z niejasnej klasyfikacji zmian w cytologii szyjki macicy, w 1989 roku stworzono system określony od miejsca powstania jako „Bethesda system”. Jego podstawowe zasady oparto na dostarczonych danych klinicznych, ocenie jakości materiału, ujednoliceniu terminologii, jak również na zaktualizowanej wiedzy o zmianach patologicznych w komórkach. Po zakończonym sukcesem włączeniu go do użytku podobne rozwiązania wdrożono do raportowania biopsji tarczycy. Można podejrzewać, że to zainspirowało członków Papanicolau Society of Cytology do opublikowania systemu klasyfikacji zmian guzowatych trzustki. Z perspektywy czasu można powiedzieć, że system Bethesda oceny zmian w szyjce macicy i w tarczycy został bardzo chętnie zaakceptowany przez patologów i klinicystów, a przedstawione klasyfikacje stworzyły fundament dla ujednoliconego postępowania klinicznego. Wydaje się, że obiektywna ocena wpływu przedstawionych propozycji na proces diagnostyczny wymaga więcej czasu.